Dear Global Risk Community member,
Now in 2023 as ESG has transitioned from a value-adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to evolving global regulations and position your life sciences organization for future success.
I am therefore delighted to announce that the brand-new program for the 2nd Annual ESG in Life Science Summit launching today and this year’s event will be
|
With only 4 weeks left until the Life Sciences Internal Audit Conference, February 8-9, 2012 in Philadelphia, PA, don’t miss out on your opportunity to attend the event!
Join key speakers, including:
Andy Weintraub, Director, Group Internal Audit at AstraZeneca
David Bolton, Internal Audit Manager at Biomet, Inc.
Tami McLaine, Director, Audit at Baxter International
Katie McCormick, Senior Manager, Corporate Analysis & Control at Boston Scientific Corporation
Jeffrey Antoon, Director, Corporate
Executive Summary: Sometimes your reputation in the industry is everything for you. Reputation is sacrosanct and hence any risk to the reputation of the company is considered high
I worked at Sony for many years. For a company such as Sony, the brand reputation is sacrosanct. Which means any incident or event which will bring bad name to the company will be considered a “high” risk event. This is much more accentuated because the company is Japanese .
For example a pharma company makes a mistake w
The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.
For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!
